Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

NCT06377579 is registered in ClinicalTrials.gov with French Innovative Leukemia Organisation as lead sponsor.

NCT NCT06377579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06377579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
Lead sponsor
French Innovative Leukemia Organisation
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2024
Completion date
June 1, 2026
Enrollment
250 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

aml, adult